Generics
Cipla launches generic liraglutide injection in the US
...
Arna Pharma signs MOU with Slate Run Pharmaceuticals
27 February 2026 - Arna Pharma Inc, an Australia-based global pharmaceutical company, and US-based Slate Run Pharmaceuticals, announced on Thursday that they have signed an MOU to establish a scaled-u...
STADA and Bio-Thera Solutions receive European marketing authorisation for Gotenfia (golimumab)
16 February 2026 - Specialty, generic and consumer healthcare medicines company STADA and Bio-Thera Solutions (SH:688177), a commercial-stage biopharmaceutical company, announced on Friday that they h...
DifGen Pharmaceuticals' Fluorometholone Ophthalmic Suspension, 0.1% receives FDA approval
13 February 2026 - Generic pharmaceutical company DifGen Pharmaceuticals announced on Thursday that it has received approval from the US Food and Drug Administration (FDA) for Fluorometholone Ophthalm...
Viatris names new chief legal officer
4 February 2026 - Global healthcare company Viatris Inc (Nasdaq:VTRS) announced on Tuesday the appointment of Matthew J Maletta as chief legal officer (CLO), effective 9 February 2026.This follows the...
Alvotech signs biosimilar supply and commercialisation deals with Sandoz
2 February 2026 -

Global biotechnology company Alvotech (NASDAQ: ALVO), which develops and manufactures biosimilar medicines, said on Monday it ha...